The Screening Conversation Has Changed
There was a time when breast cancer screening felt like a simple equation: schedule your annual mammogram, show up, get your results, repeat next year. For many women, that routine still holds. But for a growing number — particularly those navigating dense breast tissue, elevated risk, or prior callback experiences — the equation has gotten more complicated.
New imaging technologies have entered the clinical landscape. Conversations about supplemental screening are happening in more doctor’s offices. And women across the United States are increasingly asking questions that go beyond “did my mammogram come back normal” — questions about what their imaging actually showed, what it might have missed, and whether a different approach might serve them better.
Koning Vera 3D breast CT is one of the technologies at the center of those conversations. This blog takes a direct, comparative look at what it offers and what that means for real patients making real decisions about their care.
Starting With Mammography: What It Does Well and Where It Falls Short
To understand the value proposition of dedicated breast CT, you have to start with an honest assessment of the technology it’s being compared to.
Mammography has a strong track record. Decades of population-level data support its effectiveness in reducing breast cancer mortality. The technology is widely available across the United States, the exam is fast, and the cost is manageable — typically covered by insurance for annual screening in women over 40.
But mammography is a two-dimensional projection of a three-dimensional structure. That fundamental characteristic creates two persistent problems.
The first is tissue overlap. When you project a three-dimensional breast onto a two-dimensional image, tissues at different depths overlap in ways that can obscure findings. A cancer sitting behind a dense cluster of fibroglandular tissue may be completely hidden — not because the mammogram was performed poorly, but because of the inherent geometry of the imaging method.
The second is the density problem described earlier. In dense breast tissue, the visual similarity between normal fibroglandular tissue and potential tumors creates masking that reduces sensitivity in exactly the population — younger women, women with strong family histories — who most need reliable detection.
These aren’t edge-case limitations. They affect a substantial proportion of women who undergo mammography every year.
How Dedicated Breast CT Addresses the Core Limitations
The koning vera 3d breast ct addresses both of the core limitations of mammography through a fundamentally different imaging approach.
Three-dimensional volumetric imaging eliminates tissue overlap entirely. Because the full breast volume is captured in three dimensions and can be reviewed in any plane, there is no compression of spatial information and no hiding of one structure behind another. Clinicians navigate through the tissue, examining any cross-section they choose at the resolution the system provides.
The impact on dense breast tissue is particularly significant. Dense fibroglandular tissue and masses that might be visually indistinguishable on a mammogram can be differentiated in three-dimensional CT imaging based on spatial characteristics, shape, margins, and density values that the 3D reconstruction preserves and makes accessible.
For women who have been told their mammograms are harder to read because of breast density, or who have had callbacks that resolved into nothing — often the result of overlapping tissues that looked concerning in two dimensions — the shift to volumetric imaging can be genuinely clarifying.
The Compression Question
This dimension of the comparison matters more than it might seem from a purely clinical standpoint, because it directly affects whether women actually show up for their screening.
Mammography requires breast compression — flattening the tissue between plates to improve image quality and reduce radiation dose. For most women, this ranges from uncomfortable to painful. For women with breast implants, previous surgeries, or certain physical conditions, it can be a genuine barrier to compliance.
Studies consistently show that a meaningful percentage of women delay or avoid mammography specifically because of discomfort with compression. That avoidance has clinical consequences. A screening technology that doesn’t get used isn’t protecting anyone.
The prone positioning used in breast ct — lying face down with the breast hanging freely through the table opening — requires no compression whatsoever. The breast is imaged in its natural, uncompressed state. For women whose compliance with screening has been impacted by mammography discomfort, this is not a trivial distinction.
Radiation Dose: A Transparent Discussion
Dedicated breast CT uses ionizing radiation, and any responsible discussion of the technology needs to address dose directly.
Early versions of dedicated breast CT systems operated at dose levels higher than standard mammography, which was a legitimate concern for routine screening applications. Ongoing development has focused significantly on dose reduction, and current systems — including the Koning Vera — have substantially improved dose efficiency through detector advances and reconstruction algorithm optimization.
Dose comparison between dedicated breast CT and mammography is complicated by the fact that they’re measuring different things — the absorbed dose in CT is distributed across the three-dimensional volume of the breast, while mammography dose is typically reported as mean glandular dose in a compressed breast. Direct comparisons require careful methodology.
The current clinical position is that dedicated breast CT dose is within acceptable ranges for use in appropriate patient populations — and that for women with dense breast tissue or elevated risk, the clinical benefit of improved detection justifies the radiation exposure in the context of a thoughtful screening program designed with their specific risk profile in mind.
Your radiologist and referring physician are the right people to discuss this tradeoff in the context of your individual situation.
The Diagnostic and Characterization Use Case
Beyond screening, dedicated breast CT has a significant role in diagnostic and characterization applications — situations where a finding has been identified and needs to be better understood before clinical decisions are made.
The three-dimensional visualization of the Koning Vera enables detailed assessment of lesion morphology, margins, and spatial relationships that can differentiate benign from suspicious findings with a level of confidence that two-dimensional imaging often can’t provide. In some cases, this level of characterization can prevent a biopsy that would have been recommended based on less definitive imaging. In others, it provides the detailed roadmap that makes surgical planning or biopsy guidance more precise.
For women navigating the anxiety of a callback after a screening mammogram, the prospect of getting more definitive answers from a single additional imaging study — rather than proceeding through a cascade of tests — has real value that extends beyond the clinical.
Insurance and Access: The Practical Reality
It would be incomplete to discuss Koning Vera 3D breast CT without acknowledging the current state of insurance coverage and geographic availability, because these practical factors shape real patient access.
Coverage for dedicated breast CT as a screening modality is still evolving across insurers. Some plans cover it for specific indications — dense breast tissue, elevated risk, prior abnormal findings — while others haven’t yet updated their coverage policies to reflect the technology’s expanding evidence base. The out-of-pocket cost in cases where insurance doesn’t cover the exam is a real barrier for some patients.
Geographic availability is also currently concentrated in larger metropolitan areas and academic medical centers, though this is expanding as clinical adoption grows.
If you’re interested in whether this technology is available and covered for your situation, the most productive path is a direct conversation with your imaging center and your insurance provider — and with your physician about whether your clinical situation supports a coverage argument if the initial answer is no.
Make Your Next Screening Decision an Informed One
The conversation about breast imaging has genuinely expanded beyond the standard mammography-only framework, and women who engage with that expanded conversation are better positioned to make screening decisions that reflect their actual risk profile and imaging needs.
If you have dense breast tissue, a history of mammography callbacks, elevated risk factors, or simply want to understand whether Koning Vera 3D breast CT might offer advantages for your specific situation, the next step is a conversation with your breast imaging team.
Ask the questions. Understand your options. Advocate for the screening approach that gives you the best chance of catching what matters early.
